Lipo-Immuno Tech
PrivateLast Round
Accelerator
Apr 10, 2025
Total Funding Raised
$3.02M
Company Overview
Lipo-Immuno Tech operates in Healthcare & Life Sciences and is based in Mount Pleasant, South Carolina. Its latest recorded funding round was an Accelerator round in April 2025.
Lipo-Immuno Tech is a biotechnology company that develops anti-cancer strategies utilizing lipid metabolism/signaling and immunotherapy, with potential applications for neurodegenerative disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2G
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lipo-Immuno Tech Comparables
Compare Lipo-Immuno Tech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MPC Therapeutics AG | 74% | |
| TATUM Bioscience | 68% | |
| Bexion Pharmaceuticals | 68% |
For institutional investors. Book with your work email.
Lipo-Immuno Tech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Apr 10, 2025 | ||||
| Grant | Jul 23, 2024 | ||||
| Grant | Sep 15, 2023 | ||||
| Grant | Apr 4, 2023 | ||||
| Grant | Feb 15, 2020 |
For institutional investors. Book with your work email.
Lipo-Immuno Tech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| NIH RADx | Grant |
| SCbioDrive | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 10, 2025
Raised an Accelerator round with SCbioDrive as an investor.
- Jul 23, 2024
$1M grant awarded by NIH RADx
For institutional investors. Book with your work email.
Lipo-Immuno Tech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lipo-Immuno Tech's valuation, stock price, and market status.
Is Lipo-Immuno Tech a public or private company?
Lipo-Immuno Tech is a private company.
What is the current stock price of Lipo-Immuno Tech?
Lipo-Immuno Tech is a private company, so its shares have no public market price. Caplight tracks Lipo-Immuno Tech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lipo-Immuno Tech worth (valuation)?
Valuation information for Lipo-Immuno Tech is not publicly available.
Can I buy Lipo-Immuno Tech stock?
Lipo-Immuno Tech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lipo-Immuno Tech's last funding round?
Lipo-Immuno Tech's most recent funding round was Accelerator on April 10, 2025.
Who are the main investors in Lipo-Immuno Tech?
Key investors in Lipo-Immuno Tech include National Cancer Institute, NIH RADx.
Will Lipo-Immuno Tech IPO soon?
No public IPO plans have been announced for Lipo-Immuno Tech.
How can I track Lipo-Immuno Tech secondary market activity?
Caplight tracks bids, offers, and trades in Lipo-Immuno Tech's shares on secondary markets.